Evidence map›Paper›PMID 18410415›Full record

ArticleThe British journal of dermatology2008

Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood.

S H Arshad, W Karmaus, R Kurukulaaratchy, A Sadeghnejad, M Huebner, S Ewart

Open access · greenAbstract read
In one paragraph

Article in The British journal of dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Sex-specific developmental trajectories of eczema from infancy to age 26 years: A birth cohort study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2017
    Article
  9. Article
  10. Article
  11. Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis.International journal of molecular sciences · 2016
    Review
  12. Article
  13. Article
  14. Molecular biology of atopic dermatitis.Clinical reviews in allergy & immunology · 2014
    Review
  15. Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants.Journal of the European Academy of Dermatology and Venereology : JEADV · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S H ArshadThe David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight and IIR Research Division, University of Southampton, Southampton, UK. sha@soton.ac.uk
W Karmaus
R Kurukulaaratchy
A Sadeghnejad
M Huebner
S Ewart
David Hide Asthma and Allergy Research Centre · GB

Funding

Genetic &epidemiologic cohort study of asthma &allergyR01AI061471 · NIAID · MICHIGAN STATE UNIVERSITY · PI EWART, SUSAN L · 2005 to 2009
$1.8M
NIAID NIH HHS R01 AI061471
6 · The paper itself

Abstract

backgroundAtopic eczema is characterized by Th2-dominant immunity with the cytokine interleukin 13 and the transcription factor GATA binding protein 3 playing a critical role.

objectivesWe assessed the association of polymorphisms in the IL13 and GATA3 genes with childhood eczema.

methodsA birth cohort (n = 1456) was established on the Isle of Wight in 1989 and followed at the ages of 1 (n = 1167), 2 (n = 1174), 4 (n = 1218) and 10 years (n = 1373) to determine the prevalence of allergic disease including eczema. At 4 and 10 years, skin prick testing was performed. Whole blood samples (n = 923) were obtained at the 10-year assessment, stored frozen, and genotyped. Five polymorphisms from IL13 and seven from GATA3 were genotyped for this analysis. Repeated measurement analyses were conducted for the occurrence of eczema at ages 1, 2, 4 and 10 years. All analyses were adjusted for maternal and paternal eczema, low birth weight (< 2500 g), breastfeeding >or= 3 months and age.

resultsIL13 was not associated with childhood eczema. For GATA3, the single nucleotide polymorphism (SNP) rs2275806 (promoter region) showed an increased odds ratio for atopic eczema independent of whether the comparison group had a positive skin prick test. The SNP rs444762 (intron 3 region) was associated with atopic eczema in comparison with children without eczema. The increased relative risks remained significant after adjustment for multiple testing only for rs2275806 (P < 0.05).

conclusionsA SNP in GATA3 is associated with atopic eczema. This finding highlights the importance of GATA3 as an immune-modulating gene in atopic eczema.

Indexed as

ChildChild, PreschoolCohort StudiesDermatitis, AtopicFemaleGATA3 Transcription FactorGenotypeHumansInterleukin-13MaleOdds RatioPhenotypePolymorphism, Single NucleotideSkin TestsUp-RegulationGATA3 protein, humanGATA3 Transcription FactorInterleukin-13

Identifiers

PMID18410415
PMCPMC2647137
OpenAlexW2050040086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.